Ionis Pharmaceuticals, Inc. IONS
Super Investor & Insider
1
Fondi che lo detengono
#781
Rank consenso
1.4%
% dei portafogli
$170.9M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Tweedy Browne · Tweedy Browne | 13.57% | Reduce 7.68% | 2,275,625 | $170.9M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ionis Pharmaceuticals, Inc. is a biotechnology company specializing in the discovery, development, and commercialization of human therapeutics using antisense technology. This proprietary platform enables the creation of novel drugs targeting difficult-to-treat diseases across cardiovascular, metabolic, neurological, a…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,402
TickerIONS
Statistics
Market Cap$12.32B
Revenue (TTM)$943.7M
Net Income-$381.4M
Net Margin-40.4%
EPS$-2.01
P/E-31.01
P/S11.53
P/B24.92
EV/EBITDA-37.65
ROE-67.6%
Dividend Yield—
Price$74.28
Data: Twelve Data · Revenue = mcap / P/S